{"Ticker": "NFLX", "Company": "Netflix", "Sector": "Communication Services", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$275 to $170"}, {"Date": "2022-06-14", "Rating": "Downgrade", "Organization": "The Benchmark Company", "Rating_Change": "Hold to Sell", "Target_Change": "$157"}, {"Date": "2022-06-10", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Sell", "Target_Change": "$265 to $186"}, {"Date": "2022-05-16", "Rating": "Upgrade", "Organization": "Wedbush", "Rating_Change": "Neutral to Outperform", "Target_Change": "$280"}, {"Date": "2022-04-21", "Rating": "Downgrade", "Organization": "Edward Jones", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-04-21", "Rating": "Downgrade", "Organization": "DZ Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$280"}, {"Date": "2022-04-20", "Rating": "Upgrade", "Organization": "Needham", "Rating_Change": "Underperform to Hold", "Target_Change": ""}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$300"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$355"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$460 to $300"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Pivotal Research Group", "Rating_Change": "Buy to Sell", "Target_Change": "$235"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$562 to $293"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$605 to $300"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Underperform", "Target_Change": "$605 to $300"}, {"Date": "2022-04-20", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$280"}, {"Date": "2022-04-19", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Neutral", "Target_Change": "$354"}, {"Date": "2022-03-09", "Rating": "Upgrade", "Organization": "Wedbush", "Rating_Change": "Underperform to Neutral", "Target_Change": "$342"}, {"Date": "2022-01-31", "Rating": "Upgrade", "Organization": "Edward Jones", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-01-31", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$595 to $450"}, {"Date": "2022-01-24", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$737 to $415"}, {"Date": "2022-01-21", "Rating": "Upgrade", "Organization": "The Benchmark Company", "Rating_Change": "Sell to Hold", "Target_Change": ""}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$694 to $497"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$690 to $575"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$660 to $500"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Pivotal Research Group", "Rating_Change": "Buy", "Target_Change": "$750 to $550"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$705 to $562"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Oppenheimer", "Rating_Change": "Outperform", "Target_Change": "$750 to $530"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "MoffettNathanson", "Rating_Change": "Neutral", "Target_Change": "$460 to $375"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$725 to $605"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Guggenheim", "Rating_Change": "Buy", "Target_Change": "$720 to $555"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$580 to $450"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$580 to $465"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$750 to $600"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "Canaccord Genuity", "Rating_Change": "Buy", "Target_Change": "$750 to $600"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$750 to $605"}, {"Date": "2022-01-21", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$700 to $650"}, {"Date": "2022-01-21", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$690 to $470"}, {"Date": "2022-01-21", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$575 to $420"}, {"Date": "2022-01-21", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$700 to $450"}, {"Date": "2022-01-21", "Rating": "Downgrade", "Organization": "Monness Crespi & Hardt", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2021-12-15", "Rating": "Reiterated", "Organization": "The Benchmark Company", "Rating_Change": "Sell", "Target_Change": "$485 to $470"}, {"Date": "2021-10-20", "Rating": "Reiterated", "Organization": "Monness Crespi & Hardt", "Rating_Change": "Buy", "Target_Change": "$650 to $730"}, {"Date": "2021-10-20", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$590"}, {"Date": "2021-09-29", "Rating": "Reiterated", "Organization": "The Benchmark Company", "Rating_Change": "Sell", "Target_Change": "$448 to $493"}, {"Date": "2021-09-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$590"}, {"Date": "2021-09-08", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$625 to $705"}, {"Date": "2021-09-07", "Rating": "Reiterated", "Organization": "Atlantic Equities", "Rating_Change": "Overweight", "Target_Change": "$690 to $780"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$560 to $580"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$650 to $645"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$600 to $625"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$575 to $590"}, {"Date": "2021-07-21", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$586 to $643"}, {"Date": "2021-06-25", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Neutral to Outperform", "Target_Change": "$586"}, {"Date": "2021-06-25", "Rating": "Initiated", "Organization": "Edward Jones", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2021-05-19", "Rating": "Resumed", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$620"}, {"Date": "2021-04-21", "Rating": "Upgrade", "Organization": "Stifel", "Rating_Change": "Hold to Buy", "Target_Change": "$550 to $560"}, {"Date": "2021-04-21", "Rating": "Resumed", "Organization": "Oppenheimer", "Rating_Change": "Outperform", "Target_Change": "$620"}, {"Date": "2021-04-21", "Rating": "Reiterated", "Organization": "Pivotal Research Group", "Rating_Change": "Buy", "Target_Change": "$750 to $720"}, {"Date": "2021-04-06", "Rating": "Resumed", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$665"}, {"Date": "2021-04-01", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$605"}]}